Rheumatoid Arthritis Treatment with Filgotinib: Week 132 Safety Data from a Phase 2b Open-Label Extension Study

被引：0

作者：

Kavanaugh, Arthur ^{[1
]}

Genovese, Mark C. ^{[2
]}

Winthrop, Kevin ^{[3
]}

Creenwald, Maria ^{[4
]}

Ponce, Lucia ^{[5
]}

Sosa, Favio Enriquez ^{[6
]}

Stanislavchuk, Mykola ^{[7
]}

Mazur, Minodora ^{[8
]}

Spindler, Alberto ^{[9
]}

Cseuz, Regina ^{[10
]}

Nikulenkova, Natalya ^{[11
]}

Glowacka-Kulesz, Maria ^{[12
]}

Szombati, Istvan ^{[13
]}

Dudek, Anna ^{[14
]}

Mozaffarian, Neelufar ^{[15
]}

Greer, Joy ^{[15
]}

Kunder, Rebecca ^{[15
]}

An, Di ^{[15
]}

Meulener, Luc ^{[16
]}

Besuyen, Robin ^{[16
]}

Alten, Rieke ^{[17
]}

Westhovens, Rene ^{[18
]}

机构：

[1] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA

[2] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA

[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[4] Desert Med Adv, Palm Desert, CA USA

[5] Cons Priv Temuco, Temuco, Chile

[6] Clinstile SA CV, Mexico City, DF, Mexico

[7] Vinnytsia Reg Clin Hosp, Rheumatol, Vinnytsia, Ukraine

[8] IMSP Inst Cardiol, Kishinev, Moldova

[9] Ctr Med Privado Reumatol, San Miguel De Tucuman, Tucuman, Argentina

[10] Revita Reumatol Kft, Budapest, Hungary

[11] Vladimir Reg Clin Hosp, Vladimir, Russia

[12] Silesiana Ctr Med, Wroclawska, Poland

[13] Qualiclin Kft, Budapest, Hungary

[14] AMED Med Ctr, Warsaw, Poland

[15] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA

[16] Galapagos NV, Mechelen, Belgium

[17] Schlosspk Klin Univ Med, Berlin, Germany

[18] Univ Hosp KU Leuven, Rheumatol, Leuven, Belgium

来源：

ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷

关键词：

GLPG0634/GS-6034; INHIBITOR;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2551

引用

页数：2

共 50 条

[1] Rheumatoid arthritis treatment with filgotinib: Week 156 safety and efficacy data from a phase 2b open-label extension study
Besuyen, R.
Kavanaugh, A.
Westhovens, R.
Winthrop, K.
Lee, S.
Greer, J.
DeZure, A.
An, D.
Ye, L.
Sundy, J.
Meuleners, L.
Alten, R.
Genovese, M.
[J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S452 - S452
[2] Rheumatoid Arthritis Treatment with Filgotinib: Week 156 Safety and Efficacy Data from a Phase 2b Open-Label Extension Study
Kavanaugh, Arthur
Westhovens, Rene
Winthrop, Kevin
Lee, Susan
Greer, Joy
DeZure, Adam
An, Di
Ye, Lei
Sundy, John
Besuyen, Robin
Meuleners, Luc
Alten, Rieke
Genovese, Mark
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[3] Long Term Safety of Filgotinib in the Treatment of Rheumatoid Arthritis: Week 84 Data from a Phase 2b Open-Label Extension Study
Genovese, Mark C.
Kavanaugh, Arthur
Winthrop, Kevin
Greenwald, Maria
Ponce, Lucia
Enriquez Sosa, Favio
Stanislavchuk, Mykola
Mazur, Minodora
Spindler, Alberto
Cseuz, Regina
Nikulenkova, Natalya
Glowacka-Kulesz, Maria
Szombati, Istvan
Dudek, Anna
Mozaffarian, Neelufar
Greer, Joy
Ding, Xiao
Harrison, Pille
Van der Aa, Annegret
Westhovens, Rene
Alten, Rieke
[J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
[4] LONG TERM SAFETY OF FILGOTINIB IN THE TREATMENT OF RHEUMATOID ARTHRITIS: WEEK 108 DATA FROM A PHASE 2B OPEN-LABEL EXTENSION STUDY
Westhovens, R.
Alten, R.
Winthrop, K.
Greenwald, M.
Ponce, L.
Enriquez-Sosa, F.
Stanislavchuk, M.
Mazur, M.
Spindler, A.
Cseuz, R.
Nikulenkova, N.
Glowacka-Kulesz, M.
Szombati, I.
Dudek, A.
Mozaffarian, N.
Greer, J.
Kunder, R.
An, D.
Harrison, P.
Van der Aa, A.
Kavanaugh, A.
Genovese, M.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 960 - 961
[5] Long-term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study
Coates, Laura
Mease, Philip
Gladman, Dafna
Van den Bosch, Filip
Rychlewska-Hanczewska, Anna
Tasset, Chantal
Meuleners, Luc
Trivedi, Mona
Gao, Jingjing
Besuyen, Robin
Helliwell, Philip
[J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
[6] Long-Term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study
Gladman, Dafna
Coates, Laura
Mease, Philip
van den Bosch, Filip
Rychlewska-Hanczewska, Anna
Tasset, Chantal
Meuleners, Luc
Trivedi, Mona
Guo, Ying
Besuyen, Robin
Helliwell, Philip
[J]. JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1066 - 1067
[7] LONG TERM SAFETY AND EFFICACY OF FILGOTINIB IN A PHASE 2B OPEN LABEL EXTENSION STUDY IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS UP TO 144 WEEKS
Alten, R.
Westhovens, R.
Kavanaugh, A.
Genovese, M.
Winthrop, K.
Greenwald, M.
Ponce, L.
Enriquez, F.
Stanislavchuk, M.
Mazur, M.
Spindler, A.
Cseuz, R.
Nikulenkova, N.
Glowacka-Kulesz, M.
Szombati, I.
Dudek, A.
Meuleners, L.
Tasset, C.
Harrison, P.
Van der Aa, A.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 267 - 267
[8] Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs
Kavanaugh, Arthur
Westhovens, Rene R.
Winthrop, Kevin L.
Lee, Susan J.
Tan, YingMeei
An, Di
Ye, Lei
Sundy, John S.
Besuyen, Robin
Meuleners, Luc
Stanislavchuk, Mykola
Spindler, Alberto J.
Greenwald, Maria
Alten, Rieke
Genovese, Mark C.
[J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (08) : 1230 - 1238
[9] THE EFFECT OF FILGOTINIB ON ENTHESITIS: 100-WEEK DATA FROM AN OPEN-LABEL EXTENSION STUDY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
Helliwell, P.
Coates, L. C.
Van den Bosch, F.
Gladman, D. D.
Gheyle, L.
Trivedi, M.
Alani, M.
Le Brun, F. O.
Besuyen, R.
Mease, P. J.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 792 - 793
[10] Bimekizumab Safety and Efficacy in Patients with Psoriatic Arthritis: 3-Year Results from a Phase 2b Open-Label Extension Study
Coates, L. C.
Warren, R. B.
Ritchlin, C. T.
Gossec, L.
Merola, J. F.
Assudani, D.
Coarse, J.
Eells, J.
Ink, B.
McInnes, I. B.
[J]. SWISS MEDICAL WEEKLY, 2021, 151 : S20 - S20

← 1 2 3 4 5 →